What to know about soda sweeteners as sugar returns to American Coke
For decades, Coke and the makers of other soft drinks have generally used high fructose corn syrup or artificial sweeteners in their products manufactured in the U.S. But American consumers are increasingly looking for food and drinks with fewer and
more natural ingredients
, and beverage companies are responding.
PepsiCo
and
Dr Pepper
have sold versions of their flagship sodas sweetened with cane sugar since 2009. Coca-Cola has
sold Mexican Coke
— which uses cane sugar — in the U.S. since 2005, but it's positioned a trendy alternative and sold in glass bottles. Coke with cane sugar will likely be more widely available.
Here are some frequently asked questions about the sweeteners in U.S. sodas:
What's the difference between cane sugar and high fructose corn syrup?
Many consumers know that consuming too many sweets can negatively affect their health, but soda drinkers sometimes debate if either cane sugar or high fructose corn syrup is better (or worse) than the other.
The short answer is that it doesn't make a difference, said Marion Nestle, one of the nation's top nutrition experts and professor emeritus at New York University.
High fructose corn syrup is made of the simple sugars glucose and fructose in liquid form. Cane sugar, also known as sucrose, is made of glucose and fructose bonded, but quickly split, Nestle explained.
Both are still sugars, with about the same amount of calories.
Whether a can of Coca-Cola contains one or the other, it will still be a sugary drink with about the same amount of calories and the same potential to increase well-documented health problems from obesity and diabetes to tooth decay.
Why did soda companies switch from using sugar to high fructose corn syrup?
High fructose corn syrup costs less. According to price data from the U.S. Department of Agriculture, the wholesale price of HFCS-55, the type of corn syrup most commonly used in beverages, averaged 49.4 cents per pound last year. The average wholesale price of refined cane sugar was 60.1 cents per pound, while the average wholesale price of refined beet sugar was 51.7 cents per pound.
But high fructose corn syrup has advantages beyond price. According to a 2008 paper in the American Journal of Clinical Nutrition, high fructose corn syrup is more stable than sugar when added to acidic beverages, and it can be pumped directly from delivery trucks into storage and mixing tanks.
Why is high fructose corn syrup less expensive that sugar?
Tariffs are one reason. The U.S. has had barriers on sugar imports almost back to its founding; the first went into place in 1789, according to the Cato Institute, a think tank that advocates free markets.
Since the passage of the Farm Bill in 1981, the U.S. has had a system in place that raises duties on sugar once a certain amount has been imported. The U.S. also has domestic production controls that limit supplies, keeping prices higher.
But high fructose corn syrup is also cheaper because of the federal government's billions of dollars in subsidies for corn farmers. Loans, direct payments, insurance premium subsidies and surplus crop purchases all lower farmers' costs – and the price of the corn they grow.
Are sugar replacements used in diet sodas safe?
While cutting back on added sugars has documented benefits, replacing them with artificial sweeteners is complicated, too.
Coca-Cola Zero Sugar, introduced in 2017, uses the
artificial sweetener aspartame
and the natural sweetener stevia in its recipe.
But research suggests that aspartame may be linked to cancer. In 2023, a committee for the World Health Organization determined that aspartame should be categorized 'as possibly carcinogenic to humans.'
While that doesn't mean that diet soda causes cancer, the scientific committee concluded that there may be a possible link between aspartame and liver cancer, and that the issue should be studied further.
The U.S. Food and Drug administration disagreed with the WHO panel, citing 'significant shortcomings' in the research that backed the conclusion.
FDA officials noted that aspartame is one of the most studied food additives and said 'FDA scientists do not have safety concerns' when it is used under approved conditions.
Stevia, a plant-based sweetener, appears to be 'a safe choice,' according to the Center for Science in the Public Interest, an advocacy group.
___
Durbin reported from Detroit. Aleccia reported from Los Angeles.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
How Cuts to Research Funding Could Affect Medical Students
Joseph Alisch took a gap year after his third year of medical school to do research on clustered regularly interspaced short palindromic repeats gene editing at the National Institutes of Health (NIH) as part of the Medical Research Scholars Program. In early 2025, he began to experience some of the research cuts at the NIH. While he got to do research in his area of interest, pediatric neurology, some of the cuts and other policy changes dampened his experience. The first was a travel ban, which prevented him from attending the conference where he had planned to present his research findings. He was ultimately able to present virtually, 'though it was never quite the same experience, because you like to go there and interact with all the people,' he said. Next was a pause on purchasing laboratory products, which was problematic for him because his research required a variety of reagents. 'And so, for a while we kind of had to ration things,' he said. Then things became even more difficult. 'So, there were moments we're like, 'Okay, we can purchase things.' And then that policy was pulled back, saying, 'Actually, we can't purchase things right now.'' He recalls thinking, 'I just don't know what's going to happen, but I hope for the best and that we can continue working on these projects with minimal disruptions.' But the shifting policies and delays ultimately interfered with his research. 'I was able to come out with something towards the end, but not the end product that I had envisioned when I did, when I started that gap year,' he told Medscape Medical News . Many premed and medical students pursue research opportunities to bolster their applications to medical school or residency. However, based on the current national landscape, these opportunities are now more limited. This year, the Trump administration made policy changes that limited federal research funding. For example, NIH capped reimbursement for indirect research expenses such as lab maintenance and operations at 15% for current and new grants. Comparatively, average indirect funding reported by NIH generally ranged between 27% and 28%. In announcing the cap in February, NIH said in a statement on its website that, 'Although cognizant that grant recipients, particularly 'new or inexperienced organizations,' use grant funds to cover indirect costs like overhead, NIH is obligated to carefully steward grant awards to ensure taxpayer dollars are used in ways that benefit the American people and improve their quality of life.' The statement went on to say that many private foundations that fund academic research provide substantially lower funding for indirect expenses, yet 'universities readily accept grants from these foundations.' The idea, the statement said, is 'the United States should have the best medical research in the world. It is accordingly vital to ensure that as many funds as possible go towards direct scientific research costs rather than administrative overhead.' Medscape Medical News reached out to the White House Office of Science and Technology Policy for comment on how the Trump administration's policy changes and federal funding cuts may affect medical trainees. The office did not respond. Several state attorneys general, higher education associations, and research universities have filed lawsuits in protest. A US district judge blocked the 15% cap. However, the Trump administration appealed, and the fate of the policy remains in flux. Some Physician Researchers Are Nervous 'NIH has been very steady and very reliable, in fact much more reliable than industry funding…,' said Srihari S. Naidu, MD, an interventional cardiologist and professor of medicine at New York Medical College in Valhalla, New York. 'This is the first time where…we're all on edge that money may not come through.' Srihari S. Naidu, MD Overall, 'this is the kind of thing that will have…downstream consequences that affect the health of our country because these new discoveries and the research are what have evolved health care,' said Bobby Mukkamala, MD, president of the American Medical Association. The government is probably trying to save money, but how they're doing it is 'very drastic,' Naidu said. And in his view, the consequences may be chilling for students interested in doing research. 'We know that a lot of graduate programs, as well as programs that fund research opportunities for medical students, have had delays in or cuts in funding,' added Kenira Thompson, PhD, MBA, director of research at Ponce Research Institute in Ponce, Puerto Rico. 'And that's resulted in, particularly in graduate programs, either delayed or limited new admissions because there are reduced funding pipelines.' Students will still get into medical school, Naidu said, but there'll just be fewer research opportunities. 'And if you have less research opportunities for them, you have a workforce that is less savvy about research and…with less abilities towards research, which ultimately limits…their options as a career,' Naidu said. '…And then you'll also have less innovation in that field because there's less minds, less brainpower in that field doing research,' he said. And there are probably more cuts to come. In President Trump's proposed 2026 budget, NIH faces a budget cut of almost $18 billion, or about a 40% cut in funding. According to reporting by The New York Times , a new analysis by the American Association for the Advancement of Science found that President Trump's budget proposals for fiscal year 2026 include a 34% drop in basic science research from $45 billion to $30 billion and a 22% drop for overall science funding from $198 billion to $154 billion. 'The bottom line is that yes, everything is trickling down to impact students,' Thompson said. Implications for Medical Trainees 'The students are going to see either reduced [research] slots or an increase in the competition for the slots that are available,' Thompson said. 'Certainly, if the students don't have sufficient research under their belt, then potentially it will limit their possibility of getting into a medical program.' Naidu is also worried that the quality of research opportunities will suffer. What are the other options? There are registries that students can learn to use for research, but this is not going to be on the same magnitude or caliber as basic science research or clinical research, he said. 'It won't be clearly as innovative because the innovative thing takes a lot of money.' Research Options in New Reality A research vacuum could form where philanthropy, private equity, and industry players may 'pour more money to make up the difference.' However, this increase in profit-driven research would create its own set of problems, Naidu said. One is that this type of research has a bias in favor of trying to prove something. 'And number two, all the money goes towards things that can be commercialized rather than things that might be important,' he said. For example, in his field of interventional cardiology, 'if you have a new stent, industry just wants to prove that the new stent is better than the old stent. But we might want to know if no stents are better than having a stent altogether… And an industry that makes stents is not going to do a trial about whether it's better to not have stents at all.' 'NIH is where you go when you need money to [address] the real important questions that society needs to know,' Naidu said. For example, interventional cardiologists may want to know which is better: stents vs bypass surgery, and stents vs medical therapy. 'Most of those big trials are done through NIH funding.' Given the new research realities, medical students and residents may have to consider research that is industry- or private-equity-sponsored, if those options are even available to them, Naidu said. Most of the industry research doesn't usually use medical students, residents, or fellows 'because they're tightly controlled,' he said. Kenira Thompson, PhD, MBA If the research you do is private sector-driven — based on the research agenda of a particular company that needs to focus on getting a particular medication out the door to the market as opposed to you being in a research setting where there's more independence, where you can do a deep dive into new discoveries and new ideas and sort of build on innovation — then certainly there will be an impact down the line,' Thompson said. Naidu and Thompson also envision some premed and medical students seeking research opportunities abroad. 'The greatest concern is that…there will be great inequity in terms of the opportunities available to students and that some really great students may be sort of left behind,' Thompson said. Bobby Mukkamala, MD Naturally, some students will pursue a research opportunity in other countries, Mukkamala said, but 'there's a huge expense to that as a medical student as if medical school isn't expensive enough….' 'But then, trying to figure out how am I going to get to Germany, as in this example, to collaborate with people whose funding isn't threatened on the exact same topic that I could have done here in my backyard.' Advice to Medical Students Naidu wants medical students to know that research is still a very valuable pursuit, 'both in terms of helping you get to the next stage of your career, but also in and of itself, because it might stimulate you to go into a field of research, (in) a fabulous field that can allow you to be part of scientific progress in the world.' But with decreasing funding opportunities, students may need to 'cast their net wider,' he said, and be open to different topics than they might not have considered. Naidu is trying to do his part to help with providing research opportunities. He created the Medical Research Fund at Brown University School of Medicine, his alma mater in Providence, Rhode Island, to support summer research opportunities for three medical students per year. Students may also want to ask at interviews about the status of grant funding in a given lab they're interested in working in, Mukkamala said. 'There's less opportunities, but the best and the brightest will be able to find opportunities to still do research and…learn about the process and be competitive to move on in their careers,' he said. 'But it's going to be a little harder because overall there'll be less opportunities in total.' '…This is a time in history we're making major cuts to something that has been sustainable for a long time, Naidu said, adding later, 'We would be basically going back 30 years in terms of research funding.' Alisch, now a fourth-year medical student at Brown University School of Medicine, is taking a wait-and-see approach. Despite the delays he experienced as a researcher at NIH during his gap year, Alisch said he was still quite hopeful about his future as a medical science researcher. We are only about 6-7 months into this, he said. 'We have a lot more time to go through before we can see how this is actually going to play out.'
CNN
an hour ago
- CNN
‘Worst-case scenario of famine' is unfolding in Gaza, UN-backed food security initiative says
The 'worst-case scenario of famine' is currently taking place in the Gaza Strip, according to an alert issued by the Integrated Food Security Phase Classification (IPC), a United Nations-backed initiative. 'Conflict and displacement have intensified, and access to food and other essential items and services has plummeted to unprecedented levels,' the IPC said, adding that 'mounting evidence shows that widespread starvation, malnutrition, and disease are driving a rise in hunger-related deaths.' The IPC said that the alert is intended to 'draw urgent attention to the rapidly deteriorating humanitarian situation' but doesn't constitute a formal classification of famine. 'Given the most recent information and data made available, a new IPC analysis is to be conducted without delay,' it added. More than 20,000 children were admitted for treatment for acute malnutrition between April and mid-July, the IPC said, with more than 3,000 severely malnourished. 'Latest data indicates that famine thresholds have been reached for food consumption in most of the Gaza Strip and for acute malnutrition in Gaza City,' the alert said, calling for 'immediate action' to end the hostilities and allow for 'unimpeded, large-scale, life-saving humanitarian response.' In May, the IPC reported that the enclave's entire population is experiencing 'high levels of acute food security' and the territory is at 'high risk' of famine, the most severe type of hunger crisis. Israel has come under mounting pressure by the international community to break its blockade, allow aid into Gaza and end the war. In some of his strongest remarks on the crisis, US President Donald Trump on Monday said there is 'real starvation' in Gaza, contradicting earlier statements by Israeli Prime Minister Benjamin Netanyahu, who insists there is no starvation. President Donald Trump contradicted Israeli Prime Minister Benjamin Netanyahu's assessment on starvation in Gaza and announced a plan for new "food centers" in the enclave. CNN's Nic Robertson reports from Jerusalem. 'That's real starvation stuff,' Trump told reporters in Turnberry, Scotland. 'I see it, and you can't fake that. So, we're going to be even more involved.' Trump added that the United States will set up 'food centers' in Gaza to address the crisis. Vice President JD Vance also lamented images coming out of the besieged territory. 'I don't know if you've all seen these images. You have got some really, really heartbreaking cases. You've got little kids who are clearly starving to death,' Vance told reporters Monday during a visit to Canton, Ohio. 'Israel's got to do more to let that aid in,' he said, adding that 'we've also got to wage war on Hamas so that those folks stop preventing food from coming into this territory.' Over the weekend, Israel announced a daily 'tactical pause in military activity' in three areas of Gaza to enable more aid to reach people. The military said the move would 'refute the false claim of deliberate starvation in the Gaza Strip.' Israel has also allowed foreign countries to airdrop aid into the territory, but the practice has in the past been deemed by the UN and other aid groups as costly, dangerous and insufficient. Meanwhile, the health ministry in Gaza said on Tuesday that more than 60,000 Palestinians have been killed in the territory since Israel's war on Hamas began nearly two years ago. The ministry reported that 113 people were killed in the past 24 hours, bringing the death toll to 60,034. The announcement comes as hopes dim for a ceasefire anytime soon, after talks broke up last week without an agreement. The war began after Hamas' October 7, 2023 attack on Israel killed around 1,200 people and saw another roughly 250 people taken hostage. Authorities in Gaza do not distinguish between civilians and Hamas fighters when reporting casualty figures, but the health ministry and the UN say the majority of deaths are women and children. And the true toll could be much higher, with many thousands still believed to be buried under rubble. Israel does not dispute that a significant number of Palestinian civilians have been killed in its war in Gaza. But it has long argued that figures from the Hamas-controlled health ministry are exaggerated, and that Hamas embeds itself between civilians, using them as 'human shields.' On Monday, a pair of leading Israeli human rights groups accused Israel of 'committing genocide against Palestinians in Gaza,' becoming the first such organizations to make the claim. B'Tselem said it came to that 'unequivocal conclusion' after an 'examination of Israel's policy in the Gaza Strip and its horrific outcomes, together with statements by senior Israeli politicians and military commanders about the goals of the attack.' A second Israeli group, Physicians for Human Rights Israel (PHRI), announced it was joining B'Tselem in calling Israel's actions in Gaza genocide. It published a separate legal and medical analysis documenting what it called 'deliberate and systematic extermination of the health system in Gaza.' Israeli government spokesman David Mencer dismissed the report. 'We have free speech in this country but we strongly reject this claim,' he told reporters, adding that Israel has allowed aid into Gaza. CNN's Eyad Kourdi, DJ Judd and Ivana Kottasová contributed reporting.
Newsweek
an hour ago
- Newsweek
Donald Trump's Hands Under Scrutiny in New Photos
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. New photos of President Donald Trump's hands have led to renewed scrutiny about his health. Posting on social media, users have shared images of Trump during his visit to Europe, saying his hands are "swollen and bruised." Others suggested he was wearing makeup to conceal bruises. Why It Matters Earlier this month, the White House announced that Trump, who became the oldest person sworn in as president at the beginning of his second term, had been diagnosed with chronic venous insufficiency (CVI), something his doctor described as "benign and common." CVI is a condition in which the veins in the legs are unable to efficiently return blood to the heart. It is not life-threatening. The White House's announcement came after photos of Trump at various events showed swelling in his legs and bruises on his hands, which sparked public scrutiny about his health and fitness. Some have called for the 79-year-old to release his full medical records. President Donald Trump clasps his hands as he speaks with the media during a meeting with British Prime Minister Keir Starmer at the Trump Turnberry golf course in Scotland on July 28. President Donald Trump clasps his hands as he speaks with the media during a meeting with British Prime Minister Keir Starmer at the Trump Turnberry golf course in Scotland on July 28. AP Photo/Jacquelyn Martin What To Know X users weighed in on photos taken of Trump's hands during his recent trip to Scotland, where he met EU leaders. One user posted a video of the president's hands, saying Trump's signs of CVI had been "reportedly covered with makeup." Democratic activist Chris D. Jackson posted an image and added: "Wow. Look at those swollen and bruised hands in this photo from yesterday. Trump is not well." Another user replied, "So bad they're putting makeup on them." Age was a key theme of debate in last year's presidential election, with Trump often criticizing his opponent, then-President Joe Biden, as being too old to lead. Amid the increased scrutiny over Trump's fitness, White House press secretary Karoline Leavitt said, "The president remains in excellent health." At a news briefing, she said the president's medical team found "no evidence of deep vein thrombosis or arterial disease" and that he was not experiencing any discomfort related to CVI. Leavitt added that the bruise on his hand was consistent with irritation from "frequent handshaking and the use of aspirin." What People Are Saying Sean Barbabella, the president's physician, wrote in a memo: "The president underwent a comprehensive examination, including diagnostic vascular studies. Bilateral lower extremity venous Doppler ultrasounds were performed and revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70." Dr. Brian Funaki, a leading expert in vascular and interventional radiology at the University of Chicago Medicine, previously told Newsweek: "Generally speaking it is not life-threatening in and of itself, but it can predispose to developing blood clots in the veins in the legs—which, in the worst-case scenario, could break off and migrate to the lungs, causing pulmonary emboli, which can be fatal. This is why some people with this condition are treated with anticoagulation or other means, such as an inferior vena cava filter, which is a device designed to catch migrating blood clots." What Happens Next Though Trump's medical team has said he is in good health, scrutiny over his health is likely to continue.
